New Research Opportunity For Previously Vaccinated Adults

The development and approval of an effective COVID-19 vaccine was an important milestone in our fight against COVID-19. We are grateful to all who have made the choice to protect themselves and others by receiving the COVID-19 vaccine. As the pandemic continues, an important next step is learning about the safety and effectiveness of the vaccine.

Joining a clinical trial is an important decision for you and your family. Thank you for considering this study.

Who Can Participate
You may be eligible for this study if you meet the following criteria:
  • Are 18 – 30 years old
  • Are in good general health
  • Received 2 doses of the Pfizer & BioNTech BNT162b2 COVID-19 vaccine* at least 1 year ago

*Must provide approved documentation of vaccine receipt

See if you qualify!